BioAge Labs (BIOA) Non Operating Income (2023 - 2026)

BioAge Labs has disclosed Non Operating Income across 4 years of filings, most recently posting $3.1 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $3.1 million, down 11.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.8 million (up 9.25% YoY), and the FY2025 annual result was $12.2 million, up 71.84% from the prior year.
• Non Operating Income came in at $3.1 million for Q1 2026 at BioAge Labs, up from $2.5 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $4.2 million in Q4 2024 to a low of -$7.4 million in Q4 2023.
• The 4-year median for Non Operating Income is $2.5 million (2025), against an average of $934727.3.
• Peak annual rise in Non Operating Income reached 2065.36% in 2025, while the deepest fall reached 41.41% in 2025.
• BioAge Labs' Non Operating Income stood at -$7.4 million in 2023, then jumped by 157.5% to $4.2 million in 2024, then plunged by 41.41% to $2.5 million in 2025, then advanced by 25.89% to $3.1 million in 2026.
• The last three Non Operating Income figures came in at $3.1 million (Q1 2026), $2.5 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.